APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prescription Weight Loss Pills

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prescription Weight Loss Pills Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchPrescription Weight Loss Pills Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Prescription Weight Loss Pills Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Prescription Weight Loss Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prescription Weight Loss Pills Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Prescription Weight Loss Pills Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Prescription Weight Loss Pills market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prescription Weight Loss Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prescription Weight Loss Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prescription Weight Loss Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prescription Weight Loss Pills market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prescription Weight Loss Pills market include Teva Pharmaceutical (Actavis), Sanofi (Adlyxin), Novo Nordisk A/S, Eli Lilly and Company (TRICARE), Pfizer, AstraZeneca (BYDUREON BCise), VIVUS (Qsymia), Rhythm Pharmaceuticals (Imcivree) and Haleon Group (alli), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prescription Weight Loss Pills market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prescription Weight Loss Pills and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prescription Weight Loss Pills sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prescription Weight Loss Pills market size, projected growth trends, production technologies, key applications, and end-use industries.

Prescription Weight Loss Pills Segment by Company

Teva Pharmaceutical (Actavis)

Sanofi (Adlyxin)

Novo Nordisk A/S

Eli Lilly and Company (TRICARE)

Pfizer

AstraZeneca (BYDUREON BCise)

VIVUS (Qsymia)

Rhythm Pharmaceuticals (Imcivree)

Haleon Group (alli)

Currax Pharmaceuticals (Contrave)

CHEPLAPHARM (Xenical)

Prescription Weight Loss Pills Segment by Type

Injections

Oral Tablets

Oral Capsules

Prescription Weight Loss Pills Segment by Application

Hospital

Pharmacy

Prescription Weight Loss Pills Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prescription Weight Loss Pills status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Prescription Weight Loss Pills market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prescription Weight Loss Pills significant trends, drivers, influence factors in global and regions.

6. To analyze Prescription Weight Loss Pills competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Weight Loss Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prescription Weight Loss Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Weight Loss Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prescription Weight Loss Pills market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prescription Weight Loss Pills industry.

Chapter 3: Detailed analysis of Prescription Weight Loss Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Prescription Weight Loss Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Prescription Weight Loss Pills in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prescription Weight Loss Pills Industry Trends Table 2. Prescription Weight Loss Pills Industry Drivers Table 3. Prescription Weight Loss Pills Industry Opportunities and Challenges Table 4. Prescription Weight Loss Pills Industry Restraints Table 5. Global Prescription Weight Loss Pills Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prescription Weight Loss Pills Revenue Share by Company (2021-2026) Table 7. Global Prescription Weight Loss Pills Sales Volume by Company (k units) & (2021-2026) Table 8. Global Prescription Weight Loss Pills Sales Volume Share by Company (2021-2026) Table 9. Global Prescription Weight Loss Pills Average Price (US$/unit) of Company (2021-2026) Table 10. Global Prescription Weight Loss Pills Company Ranking, (2024-2026) & (USD Million) Table 11. Global Prescription Weight Loss Pills Key Company Manufacturing Base & Headquarters Table 12. Global Prescription Weight Loss Pills Company, Product Type & Application Table 13. Global Prescription Weight Loss Pills Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Prescription Weight Loss Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injections Table 18. Significant Companies of Oral Tablets Table 19. Significant Companies of Oral Capsules Table 20. Global Prescription Weight Loss Pills Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Prescription Weight Loss Pills Sales Volume by Type (2021-2026) & (k units) Table 22. Global Prescription Weight Loss Pills Sales Volume by Type (2027-2032) & (k units) Table 23. Global Prescription Weight Loss Pills Sales Volume Share by Type (2021-2026) Table 24. Global Prescription Weight Loss Pills Sales Volume Share by Type (2027-2032) Table 25. Global Prescription Weight Loss Pills Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Prescription Weight Loss Pills Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Prescription Weight Loss Pills Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Prescription Weight Loss Pills Sales Value Share by Type (2021-2026) Table 29. Global Prescription Weight Loss Pills Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Table 32. Global Prescription Weight Loss Pills Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Prescription Weight Loss Pills Sales Volume by Application (2021-2026) & (k units) Table 34. Global Prescription Weight Loss Pills Sales Volume by Application (2027-2032) & (k units) Table 35. Global Prescription Weight Loss Pills Sales Volume Share by Application (2021-2026) Table 36. Global Prescription Weight Loss Pills Sales Volume Share by Application (2027-2032) Table 37. Global Prescription Weight Loss Pills Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Prescription Weight Loss Pills Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Prescription Weight Loss Pills Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Prescription Weight Loss Pills Sales Value Share by Application (2021-2026) Table 41. Global Prescription Weight Loss Pills Sales Value Share by Application (2027-2032) Table 42. Global Prescription Weight Loss Pills Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Prescription Weight Loss Pills Sales by Region (2021-2026) & (k units) Table 44. Global Prescription Weight Loss Pills Sales Market Share by Region (2021-2026) Table 45. Global Prescription Weight Loss Pills Sales by Region (2027-2032) & (k units) Table 46. Global Prescription Weight Loss Pills Sales Market Share by Region (2027-2032) Table 47. Global Prescription Weight Loss Pills Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Prescription Weight Loss Pills Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Prescription Weight Loss Pills Sales Value Share by Region (2021-2026) Table 50. Global Prescription Weight Loss Pills Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Prescription Weight Loss Pills Sales Value Share by Region (2027-2032) Table 52. Global Prescription Weight Loss Pills Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Prescription Weight Loss Pills Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Prescription Weight Loss Pills Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Prescription Weight Loss Pills Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 57. Global Prescription Weight Loss Pills Sales Market Share by Country (2021-2026) Table 58. Global Prescription Weight Loss Pills Sales by Country (2027-2032) & (k units) Table 59. Global Prescription Weight Loss Pills Sales Market Share by Country (2027-2032) Table 60. Global Prescription Weight Loss Pills Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Prescription Weight Loss Pills Sales Value Market Share by Country (2021-2026) Table 62. Global Prescription Weight Loss Pills Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Prescription Weight Loss Pills Sales Value Market Share by Country (2027-2032) Table 64. Teva Pharmaceutical (Actavis) Company Information Table 65. Teva Pharmaceutical (Actavis) Business Overview Table 66. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio Table 68. Teva Pharmaceutical (Actavis) Recent Development Table 69. Sanofi (Adlyxin) Company Information Table 70. Sanofi (Adlyxin) Business Overview Table 71. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio Table 73. Sanofi (Adlyxin) Recent Development Table 74. Novo Nordisk A/S Company Information Table 75. Novo Nordisk A/S Business Overview Table 76. Novo Nordisk A/S Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio Table 78. Novo Nordisk A/S Recent Development Table 79. Eli Lilly and Company (TRICARE) Company Information Table 80. Eli Lilly and Company (TRICARE) Business Overview Table 81. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio Table 83. Eli Lilly and Company (TRICARE) Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Pfizer Prescription Weight Loss Pills Product Portfolio Table 88. Pfizer Recent Development Table 89. AstraZeneca (BYDUREON BCise) Company Information Table 90. AstraZeneca (BYDUREON BCise) Business Overview Table 91. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio Table 93. AstraZeneca (BYDUREON BCise) Recent Development Table 94. VIVUS (Qsymia) Company Information Table 95. VIVUS (Qsymia) Business Overview Table 96. VIVUS (Qsymia) Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio Table 98. VIVUS (Qsymia) Recent Development Table 99. Rhythm Pharmaceuticals (Imcivree) Company Information Table 100. Rhythm Pharmaceuticals (Imcivree) Business Overview Table 101. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio Table 103. Rhythm Pharmaceuticals (Imcivree) Recent Development Table 104. Haleon Group (alli) Company Information Table 105. Haleon Group (alli) Business Overview Table 106. Haleon Group (alli) Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio Table 108. Haleon Group (alli) Recent Development Table 109. Currax Pharmaceuticals (Contrave) Company Information Table 110. Currax Pharmaceuticals (Contrave) Business Overview Table 111. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio Table 113. Currax Pharmaceuticals (Contrave) Recent Development Table 114. CHEPLAPHARM (Xenical) Company Information Table 115. CHEPLAPHARM (Xenical) Business Overview Table 116. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio Table 118. CHEPLAPHARM (Xenical) Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Prescription Weight Loss Pills Distributors List Table 122. Prescription Weight Loss Pills Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Prescription Weight Loss Pills Product Image Figure 2. Global Prescription Weight Loss Pills Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prescription Weight Loss Pills Sales Value (2021-2032) & (US$ Million) Figure 4. Global Prescription Weight Loss Pills Sales (2021-2032) & (k units) Figure 5. Global Prescription Weight Loss Pills Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Prescription Weight Loss Pills Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injections Image Figure 10. Oral Tablets Image Figure 11. Oral Capsules Image Figure 12. Global Prescription Weight Loss Pills Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Prescription Weight Loss Pills Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Prescription Weight Loss Pills Sales Volume Share by Type (2021-2032) Figure 15. Global Prescription Weight Loss Pills Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Prescription Weight Loss Pills Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Prescription Weight Loss Pills Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Global Prescription Weight Loss Pills Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Prescription Weight Loss Pills Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Prescription Weight Loss Pills Sales Volume Share by Application (2021-2032) Figure 23. Global Prescription Weight Loss Pills Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Prescription Weight Loss Pills Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Prescription Weight Loss Pills Sales Value Share by Application (2021-2032) Figure 26. Global Prescription Weight Loss Pills Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Prescription Weight Loss Pills Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Prescription Weight Loss Pills Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Prescription Weight Loss Pills Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Prescription Weight Loss Pills Sales Value (2021-2032) & (US$ Million) Figure 31. North America Prescription Weight Loss Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Prescription Weight Loss Pills Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Prescription Weight Loss Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Prescription Weight Loss Pills Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Prescription Weight Loss Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Prescription Weight Loss Pills Sales Value (2021-2032) & (US$ Million) Figure 37. South America Prescription Weight Loss Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Prescription Weight Loss Pills Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Prescription Weight Loss Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Prescription Weight Loss Pills Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Prescription Weight Loss Pills Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Injections
  • Oral Tablets
  • Oral Capsules
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Teva Pharmaceutical (Actavis)
  • Sanofi (Adlyxin)
  • Novo Nordisk A/S
  • Eli Lilly and Company (TRICARE)
  • Pfizer
  • AstraZeneca (BYDUREON BCise)
  • VIVUS (Qsymia)
  • Rhythm Pharmaceuticals (Imcivree)
  • Haleon Group (alli)
  • Currax Pharmaceuticals (Contrave)
  • CHEPLAPHARM (Xenical)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prescription Weight Loss Pills Sales Value (2021-2032)
  4. 1.2.2 Global Prescription Weight Loss Pills Sales Volume (2021-2032)
  5. 1.2.3 Global Prescription Weight Loss Pills Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Prescription Weight Loss Pills Market Dynamics
  1. 2.1 Prescription Weight Loss Pills Industry Trends
  2. 2.2 Prescription Weight Loss Pills Industry Drivers
  3. 2.3 Prescription Weight Loss Pills Industry Opportunities and Challenges
  4. 2.4 Prescription Weight Loss Pills Industry Restraints
3 Prescription Weight Loss Pills Market by Company
  1. 3.1 Global Prescription Weight Loss Pills Company Revenue Ranking in 2025
  2. 3.2 Global Prescription Weight Loss Pills Revenue by Company (2021-2026)
  3. 3.3 Global Prescription Weight Loss Pills Sales Volume by Company (2021-2026)
  4. 3.4 Global Prescription Weight Loss Pills Average Price by Company (2021-2026)
  5. 3.5 Global Prescription Weight Loss Pills Company Ranking (2024-2026)
  6. 3.6 Global Prescription Weight Loss Pills Company Manufacturing Base and Headquarters
  7. 3.7 Global Prescription Weight Loss Pills Company Product Type and Application
  8. 3.8 Global Prescription Weight Loss Pills Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Prescription Weight Loss Pills Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Prescription Weight Loss Pills Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Prescription Weight Loss Pills Market by Type
  1. 4.1 Prescription Weight Loss Pills Type Introduction
  2. 4.1.1 Injections
  3. 4.1.2 Oral Tablets
  4. 4.1.3 Oral Capsules
  5. 4.2 Global Prescription Weight Loss Pills Sales Volume by Type
  6. 4.2.1 Global Prescription Weight Loss Pills Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Prescription Weight Loss Pills Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Prescription Weight Loss Pills Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Prescription Weight Loss Pills Sales Value by Type
  10. 4.3.1 Global Prescription Weight Loss Pills Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Prescription Weight Loss Pills Sales Value by Type (2021-2032)
  12. 4.3.3 Global Prescription Weight Loss Pills Sales Value Share by Type (2021-2032)
5 Prescription Weight Loss Pills Market by Application
  1. 5.1 Prescription Weight Loss Pills Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Prescription Weight Loss Pills Sales Volume by Application
  5. 5.2.1 Global Prescription Weight Loss Pills Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Prescription Weight Loss Pills Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Prescription Weight Loss Pills Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Prescription Weight Loss Pills Sales Value by Application
  9. 5.3.1 Global Prescription Weight Loss Pills Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Prescription Weight Loss Pills Sales Value by Application (2021-2032)
  11. 5.3.3 Global Prescription Weight Loss Pills Sales Value Share by Application (2021-2032)
6 Prescription Weight Loss Pills Regional Sales and Value Analysis
  1. 6.1 Global Prescription Weight Loss Pills Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prescription Weight Loss Pills Sales by Region (2021-2032)
  3. 6.2.1 Global Prescription Weight Loss Pills Sales by Region: 2021-2026
  4. 6.2.2 Global Prescription Weight Loss Pills Sales by Region (2027-2032)
  5. 6.3 Global Prescription Weight Loss Pills Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Prescription Weight Loss Pills Sales Value by Region (2021-2032)
  7. 6.4.1 Global Prescription Weight Loss Pills Sales Value by Region: 2021-2026
  8. 6.4.2 Global Prescription Weight Loss Pills Sales Value by Region (2027-2032)
  9. 6.5 Global Prescription Weight Loss Pills Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Prescription Weight Loss Pills Sales Value (2021-2032)
  12. 6.6.2 North America Prescription Weight Loss Pills Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Prescription Weight Loss Pills Sales Value (2021-2032)
  15. 6.7.2 Europe Prescription Weight Loss Pills Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Prescription Weight Loss Pills Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Prescription Weight Loss Pills Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Prescription Weight Loss Pills Sales Value (2021-2032)
  21. 6.9.2 South America Prescription Weight Loss Pills Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Prescription Weight Loss Pills Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Prescription Weight Loss Pills Sales Value Share by Country, 2025 VS 2032
7 Prescription Weight Loss Pills Country-level Sales and Value Analysis
  1. 7.1 Global Prescription Weight Loss Pills Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prescription Weight Loss Pills Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Prescription Weight Loss Pills Sales by Country (2021-2032)
  4. 7.3.1 Global Prescription Weight Loss Pills Sales by Country (2021-2026)
  5. 7.3.2 Global Prescription Weight Loss Pills Sales by Country (2027-2032)
  6. 7.4 Global Prescription Weight Loss Pills Sales Value by Country (2021-2032)
  7. 7.4.1 Global Prescription Weight Loss Pills Sales Value by Country (2021-2026)
  8. 7.4.2 Global Prescription Weight Loss Pills Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Prescription Weight Loss Pills Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Prescription Weight Loss Pills Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Prescription Weight Loss Pills Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical (Actavis)
  2. 8.1.1 Teva Pharmaceutical (Actavis) Company Information
  3. 8.1.2 Teva Pharmaceutical (Actavis) Business Overview
  4. 8.1.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio
  6. 8.1.5 Teva Pharmaceutical (Actavis) Recent Developments
  7. 8.2 Sanofi (Adlyxin)
  8. 8.2.1 Sanofi (Adlyxin) Company Information
  9. 8.2.2 Sanofi (Adlyxin) Business Overview
  10. 8.2.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio
  12. 8.2.5 Sanofi (Adlyxin) Recent Developments
  13. 8.3 Novo Nordisk A/S
  14. 8.3.1 Novo Nordisk A/S Company Information
  15. 8.3.2 Novo Nordisk A/S Business Overview
  16. 8.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio
  18. 8.3.5 Novo Nordisk A/S Recent Developments
  19. 8.4 Eli Lilly and Company (TRICARE)
  20. 8.4.1 Eli Lilly and Company (TRICARE) Company Information
  21. 8.4.2 Eli Lilly and Company (TRICARE) Business Overview
  22. 8.4.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio
  24. 8.4.5 Eli Lilly and Company (TRICARE) Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Prescription Weight Loss Pills Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Prescription Weight Loss Pills Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 AstraZeneca (BYDUREON BCise)
  32. 8.6.1 AstraZeneca (BYDUREON BCise) Company Information
  33. 8.6.2 AstraZeneca (BYDUREON BCise) Business Overview
  34. 8.6.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio
  36. 8.6.5 AstraZeneca (BYDUREON BCise) Recent Developments
  37. 8.7 VIVUS (Qsymia)
  38. 8.7.1 VIVUS (Qsymia) Company Information
  39. 8.7.2 VIVUS (Qsymia) Business Overview
  40. 8.7.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio
  42. 8.7.5 VIVUS (Qsymia) Recent Developments
  43. 8.8 Rhythm Pharmaceuticals (Imcivree)
  44. 8.8.1 Rhythm Pharmaceuticals (Imcivree) Company Information
  45. 8.8.2 Rhythm Pharmaceuticals (Imcivree) Business Overview
  46. 8.8.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio
  48. 8.8.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments
  49. 8.9 Haleon Group (alli)
  50. 8.9.1 Haleon Group (alli) Company Information
  51. 8.9.2 Haleon Group (alli) Business Overview
  52. 8.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio
  54. 8.9.5 Haleon Group (alli) Recent Developments
  55. 8.10 Currax Pharmaceuticals (Contrave)
  56. 8.10.1 Currax Pharmaceuticals (Contrave) Company Information
  57. 8.10.2 Currax Pharmaceuticals (Contrave) Business Overview
  58. 8.10.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio
  60. 8.10.5 Currax Pharmaceuticals (Contrave) Recent Developments
  61. 8.11 CHEPLAPHARM (Xenical)
  62. 8.11.1 CHEPLAPHARM (Xenical) Company Information
  63. 8.11.2 CHEPLAPHARM (Xenical) Business Overview
  64. 8.11.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio
  66. 8.11.5 CHEPLAPHARM (Xenical) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prescription Weight Loss Pills Value Chain Analysis
  2. 9.1.1 Prescription Weight Loss Pills Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prescription Weight Loss Pills Sales Mode & Process
  6. 9.2 Prescription Weight Loss Pills Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prescription Weight Loss Pills Distributors
  9. 9.2.3 Prescription Weight Loss Pills Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst